Yasuko Satoh

540 total citations
19 papers, 304 citations indexed

About

Yasuko Satoh is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yasuko Satoh has authored 19 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Yasuko Satoh's work include Lung Cancer Treatments and Mutations (5 papers), Fibroblast Growth Factor Research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yasuko Satoh is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Fibroblast Growth Factor Research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yasuko Satoh collaborates with scholars based in Japan and United States. Yasuko Satoh's co-authors include Toshiyuki Tsukaguchi, Osamu Kondoh, Hiroshi Sakamoto, Tatsushi Kodama, Miyuki Yoshida, Yoshiaki Watanabe, Nobuya Ishii, Toshihiko Fujii, Masahiro Aoki and Yoshito Nakanishi and has published in prestigious journals such as Cancer Research, Applied Surface Science and European Journal of Pharmacology.

In The Last Decade

Yasuko Satoh

19 papers receiving 286 citations

Peers

Countries citing papers authored by Yasuko Satoh

Since Specialization

Citations

This map shows the geographic impact of Yasuko Satoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuko Satoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuko Satoh more than expected).

Fields of papers citing papers by Yasuko Satoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuko Satoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuko Satoh. The network helps show where Yasuko Satoh may publish in the future.

Co-authorship network of co-authors of Yasuko Satoh

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuko Satoh. A scholar is included among the top collaborators of Yasuko Satoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuko Satoh. Yasuko Satoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3–BAIAP2L1 2015 ·Molecular Cancer Therapeutics ·Yoshito Nakanishi, (unknown), Toshiyuki Tsukaguchi, Toshihiko Fujii, Yasuko Satoh, Nobuya Ishii, Masahiro Aoki	51
2	Abstract 123: Mechanism of oncogenic signal activation by the novel fusion kinase FGFR3-BAIAP2L1 2015 ·Cancer Research ·Yoshito Nakanishi, (unknown), Toshiyuki Tsukaguchi, Toshihiko Fujii, Yasuko Satoh, Hideaki Mizuno, Nobuya Ishii, Masahiro Aoki	1
3	Abstract 773: Alectinib shows potent antitumor activity against both ALK- and RET-rearranged non-small cell lung cancers 2015 ·Cancer Research ·Tatsushi Kodama, Toshiyuki Tsukaguchi, Yasuko Satoh, Miyuki Yoshida, Yoshiaki Watanabe, Osamu Kondoh, Hiroshi Sakamoto	1
4	Alectinib Shows Potent Antitumor Activity against RET -Rearranged Non–Small Cell Lung Cancer 2014 ·Molecular Cancer Therapeutics ·Tatsushi Kodama, Toshiyuki Tsukaguchi, Yasuko Satoh, Miyuki Yoshida, Yoshiaki Watanabe, Osamu Kondoh, Hiroshi Sakamoto	125
5	Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression 2014 ·Molecular Cancer Therapeutics ·Yuji Sano, Eri Hashimoto, Noriaki Nakatani, (unknown), Yasuko Satoh, Kiyoaki Sakata, Toshihiko Fujii, Kaori Fujimoto-Ouchi, Masamichi Sugimoto, Shigehisa Nagahashi, Masahiro Aoki, (unknown), Eiichi Sasaki, Yasushi Yatabe	22
6	A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line 2014 ·Journal of Thoracic Oncology ·Tatsushi Kodama, Noriko Motoi, Hironori Ninomiya, Hiroshi Sakamoto, Kunio Kitada, Toshiyuki Tsukaguchi, Yasuko Satoh, Kimie Nomura, Hiroko Nagano, Nobuya Ishii, Yasuhito Terui, Kiyohiko Hatake, Yuichi Ishikawa	16
7	Abstract 5252: Inhibition of FGFR3-BAIAP2L1 fusion kinase oncogenic potential by CH5183284/Debio 1347, a compound that inhibits FGFR3 kinase activity constitutively activated by BAIAP2L1 BAR domain dimerization 2014 ·Cancer Research ·(unknown), Yoshito Nakanishi, Toshiyuki Tsukaguchi, Yasuko Satoh, (unknown), Tsutomu Takahashi, (unknown), (unknown), Nobuya Ishii, Masahiro Aoki	2
8	Abstract LB-327: Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-D. 2013 ·Cancer Research ·Kenji Kashima, Miho Watanabe, Yasuko Satoh, Junichi Hata, Nobuya Ishii, Yuko Aoki	1
9	Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor‐D 2012 ·Cancer Science ·Kenji Kashima, Miho Watanabe, Yasuko Satoh, Junichi Hata, Nobuya Ishii, Yuko Aoki	18
10	Abstract 2728: Onartuzumab (MetMAb) restores sensitivity to erlotinib in EGFR mutant NSCLC cells expressing HGF 2012 ·Cancer Research ·Yuji Sano, Eri Hashimoto, Noriaki Nakatani, Kaori Fujimoto-Ouchi, Nobuya Ishii, Yasuko Satoh, Kiyoaki Sakata, Toshihiko Fujii, Shigehisa Nagahashi, Yuko Aoki, Masahiro Aoki	2
11	Effects of relative humidity on cocoon formation and survival in the braconid wasp Cotesia glomerata 2008 ·Physiological Entomology ·Jun Tagawa, Yasuko Satoh	1
12	Synthesis and Antifungal Activities of Novel 1,3-β-d-Glucan Synthase Inhibitors. Part 2 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Takeshi Murata, Masao Tsukazaki, Osamu Kondoh, Toshikazu Yamazaki, Yasuko Satoh, (unknown), Toshiyuki Tsukaguchi, Kazuko Kobayashi, (unknown), (unknown), Ikuo Horii, Nobuo Shimma	10
13	Synthesis and antifungal activities of novel 1,3-β-d-glucan synthase inhibitors. Part 1 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Masahiro Sakaitani, (unknown), (unknown), Masahiro Aoki, Takahide Watanabe, Osamu Kondoh, Toshikazu Yamazaki, Yasuko Satoh, Kazuko Kobayashi, (unknown), Ikuo Horii, Nobuo Shimma	18
14	Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs 1997 ·European Journal of Pharmacology ·Masayuki Shibasaki, Akira Fujimori, Toshiyuki Kusayama, (unknown), Yasuko Satoh, Toshio Okazaki, Wataru Uchida, Osamu Inagaki, Isao Yanagisawa	8
15	Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist 1997 ·European Journal of Pharmacology ·Masayuki Shibasaki, Akira Fujimori, Masahiro Takanashi, Toshiyuki Kusayama, (unknown), Yasuko Satoh, Toshio Okazaki, Wataru Uchida, Osamu Inagaki, Isao Yanagisawa	8
16	Photoemission study of 6H-SiC(0001)Si face 1997 ·Applied Surface Science ·(unknown), (unknown), Akimasa Kinoshita, Yasuko Satoh, Masaaki Hirai, M. Kusaka, Motohiro Iwami, Takao Nakata	6
17	Effect of maternal selenium deficiency on the teratogenicity of methylmercury 1988 ·Toxicology Letters ·Noriko Nishikido, Yasuko Satoh, Akira Naganuma, Nobumasa Imura	3
18	Studies on Storage and Ageing of Leaf Tobacco 1971 ·Agricultural and Biological Chemistry ·Masao Noguchi, Yasuko Satoh, (unknown), (unknown), Einosuke Tamaki	3
19	Studies on Storage and Ageing of Leaf Tobacco 1971 ·Agricultural and Biological Chemistry ·Masao Noguchi, Yasuko Satoh, (unknown), (unknown), Einosuke Tamaki	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact